Tyk2-IN-7 is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets Tyk2 JH2, and TYK2 JH2.
Molecular Weight
401.46
Molecular Formula
C18H15D3N6O3S
Targets
Tyk2 JH2: 0.00053 μM; TYK2 JH2: 0.00007 μM (Ki app)
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Tyk2-IN-7 can be used to explore its role as an inhibitor of Tyk2 for research on inflammatory and autoimmune disorders.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.